Post by
stockmonster6 on Mar 24, 2021 11:53am
Course Correction - FDA!
Interesting change of events, with focus now shifting to FDA and Europe, while continuing to work on the slower Health Canada process.
A Canadian product, will take the US market by storm. $25 million potential income per month at only $1 profit per test, could be more. $300 million profit in a year + more in other markets.
things are clicking along. I like this shift. start getting revenue from FDA approval and then still breaking into Canada.
rock and roll!!
Comment by
Vincenzovega on Mar 24, 2021 12:01pm
Rob said eventually $1.00 to produce and at their eventual lower price of $10.00... Thats $9.00 profit per test, not $1.00